Endowment Wealth Management’s Humacyte HUMA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $192K | Buy |
109,458
+5,350
| +5% | +$9.39K | 0.1% | 147 |
|
2025
Q1 | $178K | Hold |
104,108
| – | – | 0.11% | 140 |
|
2024
Q4 | $626K | Buy |
104,108
+3,590
| +4% | +$21.6K | 0.42% | 59 |
|
2024
Q3 | $485K | Hold |
100,518
| – | – | 0.32% | 67 |
|
2024
Q2 | $482K | Buy |
100,518
+3,000
| +3% | +$14.4K | 0.35% | 68 |
|
2024
Q1 | $303K | Hold |
97,518
| – | – | 0.23% | 94 |
|
2023
Q4 | $319K | Hold |
97,518
| – | – | 0.27% | 86 |
|
2023
Q3 | $286K | Hold |
97,518
| – | – | 0.26% | 96 |
|
2023
Q2 | $319K | Buy |
97,518
+900
| +0.9% | +$2.95K | 0.29% | 91 |
|
2023
Q1 | $299K | Hold |
96,618
| – | – | 0.3% | 87 |
|
2022
Q4 | $204K | Hold |
96,618
| – | – | 0.22% | 116 |
|
2022
Q3 | $315K | Hold |
96,618
| – | – | 0.38% | 71 |
|
2022
Q2 | $310K | Hold |
96,618
| – | – | 0.37% | 69 |
|
2022
Q1 | $682K | Hold |
96,618
| – | – | 0.72% | 24 |
|
2021
Q4 | $700K | Buy |
+96,618
| New | +$700K | 0.71% | 28 |
|